DONATE

Search Results for:

IBEC receives the FEI award for its support to innovation

Yesterday, the Innovative Companies Forum (“FEI”, in Spanish) celebrated the seventh edition of the 2019 “Innovation Awards”. The awards ceremony, which aims to highlight the commitment to innovation of organizations, companies and researchers, recognized the Institute for Bioengineering of Catalonia’s (or “IBEC”) “Innovation Support Agency”. David Badia, executive director of the institute, received the award during the ceremony, which took place in Madrid.

During his acceptance speech, Badia noted that IBEC is accredited as a Severo Ochoa Centre of Excellence and is dedicated to the field of bioengineering, with the objective not only to study, but to also promote the research’s application in the field of medicine, health and the improvement of people’s quality of life.

New advances in the treatment of advanced lung cancer

A research team led by Jordi Alcaraz, tenure track-2 lecturer from the Department of Biomedicine of the Faculty of Medicine and Health Sciences of the University of Barcelona and research associated at the Institute for Bioengineering of Catalonia (IBEC), in collaboration with the Hospital Clínic de Barcelona and the Boehringer Ingelheim company, has identified the molecular mechanisms than could have implications in the design of new therapeutic strategies to expand the clinical benefits of a drug to a larger spectra of patients with lung cancer.

Mechanics and epigenetics of renal organoids

Group: Cellular and molecular mechanobiology and Pluripotency for organ regeneration. Group leader: Pere Roca-Cusachs (proca@ibecbarcelona.eu) and Núria Montserrat (nmontserrat@ibecbarcelona.eu) Research project The Cellular and Molecular Mechanobiology lab at IBEC studies … Read more

IBEC launches its Clinical Colloquia Program

As a part of IBEC’s strategy to facilitate the transfer of excellent science into health solutions for patients and hospitals, the Institute fosters relations and partnerships with clinicians and companies. Within this framework, the Institute of Bioengineering of Catalonia has now launched the IBEC Clinical Colloquia Program.

Thanks to the nature of the research developed in the institute, IBEC counts on an ongoing and committed relationship with hospitals, medical doctors and patients. As a result, the involved partners are able to develop joint research projects, and in other cases they are a source of information about the unmet needs in clinical practice. With the launching of this clinical colloquia IBEC wants to strengthen these collaborations and offer the opportunity to create a space for discussion between researchers and medical doctors.

IBEC counts on collaboration of medical doctors to provide input on the clinical aspects of its research, so that results are easily extended to clinical practice.

Postdoctoral researcher at the IMEM Research Group


Application Deadline: 10/12/2019
Ref: PD-CA

The IMEM Group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Postdoctoral Researcher with broad experience in (Bio)Materials, Nanotechnology and Polymers/Biopolymers to develop a project on the development of (bio)polymeric materials for biomedical applications. The contract will be within the framework of IMEM-BRT research lines, whose objective is the development of new materials for regenerative therapies.
Specifically, the project involves the study of hydrogels as versatile platforms for specific (bio)applications using new chemistries, cell-friendly polymers (biopolymers and degradable synthetic polymers) and advanced manufacturing technologies. The research will involve three different areas that derive from the function, features, and source of hydrogels and, consequently, will require a wide range of skills (as per below).

IBEC Seminar: Emilio Parisini

Drugging the undruggable: towards the development of selective modulators of cadherin-mediated cell-cell adhesion Emilio Parisi, Italian Institute of Technology (Milano) and Latvian Institute of Organic Synthesis (Riga) Cadherins are transmembrane … Read more

IBEC Seminar: Emilio Parisini

Drugging the undruggable: towards the development of selective modulators of cadherin-mediated cell-cell adhesion Emilio Parisi, Italian Institute of Technology (Milano) and Latvian Institute of Organic Synthesis (Riga) Cadherins are transmembrane … Read more

IBEC Seminar: Emilio Parisini

Drugging the undruggable: towards the development of selective modulators of cadherin-mediated cell-cell adhesion Emilio Parisi, Italian Institute of Technology (Milano) and Latvian Institute of Organic Synthesis (Riga) Cadherins are transmembrane … Read more

Cookies
Cookie Consent The IBEC website uses cookies and similar technologies to ensure the basic functionality of the site and for statistical and optimisation purposes. It also uses cookies to display content such as YouTube videos that use marketing cookies. This last category consists of tracking cookies: these make it possible for your online behaviour to be tracked. You consent to this by clicking on Accept. Also read our Privacy statement. Read our cookie policy
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy
Save Accept all